Acrylamide – no Evidence for Accumulation in End-Stage Renal Disease Patients Using Its Hemoglobin Adduct as Biomarker

Holland N. , Ahlborn T. , Turteltaub K. , Markee C. , Moore D. , Wyrobek A.J. , Smith M.T. . Acrylamide causes pre-implantation abnormalities in embryos and induces chromatin-adducts in male germ cells of mice. Reprod Toxicol 1999; 13: 167–78.

Godin A.C. , Bengtsson B. , Nishanen R. , Tarche E. , Törnquist M. , Forsland K. . Acrylamide and N-methylolacrylamide poisoning in a herd of Charolais crossbreed cattle. Vet Rec 2002; 151: 724–8.

Spencer P.S. , Schaumberg H.H. . A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposures. Can J Neurol Sci 1974; 1: 143–50.

Calleman C.J. , Wu Y. , He F. , Tian G. , Bergmark E. , Zhang S. , Deng H. . Relationship between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol 1994; 126: 361–71.

Reynolds T. . Acrylamide and cancer: Tunnel leak in Sweden prompted studies. J Natl Cancer Inst 2002; 94: 876–8.

Dearfield K.L. , Abernathy C.O. , Ottely M.S. , Branmer J.H. , Hayes P. . Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat Res 1988; 195: 45–77.

IARC, International Agency for the Research on Cancer. Acrylamide. IARC Monograph Eval Carcino Risks Hum 1994; 60: 389–434.

Smith C.J. , Perfetti T.A. , Rumple M.A. , Rogdman A. , Doolittle D.J. . “IARC Group 2A Carcinogens” reported in cigarette mainstream smoke. Food Chem Toxicol 2000; 38: 371–83.

Bergmark E. . Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem Res Toxicol 1997; 10: 78–84.

Schettgen T. , Weiss T. , Drexler H. , Angerer J. . A first approach to estimate the internal exposure to acrylamide in smoking and non-smoking adults from Germany. Int J Hyg Environ Health 2003; 206: 9–14.

Tareke E. , Rydberg P. , Karlsson P. , Eriksson S. , Törnquist M. . Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002; 50: 4998–5006.

Stadler R.H. , Blank I. , Varga H. , Robert F. , Hau J. , Guy P.A. . Acrylamide from Maillard reaction products. Nature 2002; 419: 449.

Sumner S.C.J. , Selvaraij L. , Nauhaus S.K. , Fennell T.R. . Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem Res Toxicol 1997; 10: 1152–60.

Sumner S.C.J. , Fennell T.R. , Moore T.A. , Chanas B. , Gonzalez F. , Ghanayem B.I. . Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999; 12: 1110–6.

Sega G.A. , Generoso E.E. , Brimer P.A. . Acrylamide exposure induces a delayed unscheduled DNA synthesis in germ cells of male mice that is correlated with the temporal pattern of adduct formation in testis DNA. Env Mol Mutagen 1990; 16: 137–42.

Segerbäck D. , Calleman C.J. , Schroeder J.L. , Costa L.G. , Faustman E.M. . Formation of N7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of 14C-acrylamide. Carcinogensis 1995; 16: 1161–5.

Kadry A.M. , Friedman M.A. , Abdel-Rahman M.S. . Pharmocokinetics of acrylamide after oral administration in male rats. Environ Toxicol Pharmacol 1999; 7: 127–33.

Maisonneuve P. , Agodoa L. , Gellert R. , Stewart J.H. , Buccianti G. , Lowenfels A.B. , Wolfe R.A. , Jones E. , Disney A.P. , Briggs D. , McCredie M. , Boyle P. . Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999; 354: 93–9.

Hagmar L. , Törnquist M. , Nordander C. , Rosen I. , Bruze M. , Kautiainen A. . Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 2001; 27: 219–26.

Fennell T.R. , MacNeela J.P. , Morris R.W. , Watson M. , Thompson C.L. , Bell D.A. . Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: Effect of glutathione-S-transferase T1-Null and M1-Null genotypes. Cancer Epidemiol Biomarkers Prev 2000; 9: 705–12.

van Sittert N.J. . N-2-cyanoethylvaline, N-2-hydroxyethylvaline, N-methylvaline. In: Angerer J. , Schaller K.H. , eds. Analysis of hazardous substances in biological materials. Wiley-VCH, Weinheim 1996; (suppl): S181–210.